Speech News and Research RSS Feed - Speech News and Research

Professor Tiago H. Falk receives CMBES Early Career Achievement Award

Professor Tiago H. Falk receives CMBES Early Career Achievement Award

Professor Tiago H. Falk of the INRS Énergie Matériaux Télécommunications Research Centre has received the Canadian Medical and Biological Engineering Society (CMBES) Early Career Achievement Award in recognition of the outstanding scientific contributions the young researcher has made over the past five years. [More]
Cosmetic surgery could improve lives of people with facial paralysis

Cosmetic surgery could improve lives of people with facial paralysis

A cosmetic surgery that uses injections of hyaluronic acid to make lips appear fuller could also improve the lives of people with facial paralysis, according to results of a small study by researchers at Johns Hopkins and Stanford universities. [More]
NYU Langone receives $25 million to establish Fresco Institute for PD and movement disorders

NYU Langone receives $25 million to establish Fresco Institute for PD and movement disorders

NYU Langone Medical Center today announced that the Paolo and Marlene Fresco Foundation (Fresco Foundation) has generously given $25 million to establish the international Marlene and Paolo Fresco Institute for Parkinson's & Movement Disorders. [More]

'Brain-to-Text' system decodes spoken speech and transforms it into textual representation

Speech is produced in the human cerebral cortex. Brain waves associated with speech processes can be directly recorded with electrodes located on the surface of the cortex. It has now been shown for the first time that is possible to reconstruct basic units, words, and complete sentences of continuous speech from these brain waves and to generate the corresponding text. [More]
Novartis presents positive Phase III results of Farydak therapy at EHA

Novartis presents positive Phase III results of Farydak therapy at EHA

Novartis today presented results from a pivotal Phase III clinical trial exploratory subgroup analysis showing a 7.8-month improvement in median progression-free survival when using Farydak in combination with bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma who had received two or more prior regimens, including bortezomib and an immunomodulatory agent. [More]
Brain Injury Services of SWVA receives WWP grant to provide tele-health program for veterans with TBI

Brain Injury Services of SWVA receives WWP grant to provide tele-health program for veterans with TBI

Brain Injury Services of SWVA has received a grant from Wounded Warrior Project (WWP) to provide a unique tele-health program, the Community Living Connection (CLiC) for veterans with traumatic brain injury (TBI), to overcome the diverse challenges of the complex condition. WWP's Grant Program, now in its fourth year, is expanding the availability of programs and services that provide support to this generation of injured service members. [More]
UT Southwestern researchers reveal how the body controls glucose transport

UT Southwestern researchers reveal how the body controls glucose transport

UT Southwestern Medical Center scientists have gleaned a key cellular mechanism of how the body adjusts glucose levels, an important process that when abnormal can promote diabetes, cancer, and rare genetic diseases. [More]
NYU Langone Medical Center celebrates 65th anniversary of Rusk Rehabilitation

NYU Langone Medical Center celebrates 65th anniversary of Rusk Rehabilitation

Howard A. Rusk, MD (1901-1989), a tall, soft-spoken physician from NYU Langone Medical Center and widely considered "the father of rehabilitation medicine," set about to establish a facility founded on the belief that care should focus on the whole person—not just on their physical illness or disability, but also on their emotional, psychological, and social needs as well. [More]
Manchester first to implement Congenica's Sapientia technology to provide fast, accurate diagnosis for genetic diseases

Manchester first to implement Congenica's Sapientia technology to provide fast, accurate diagnosis for genetic diseases

10,000 new patients a year are treated by the Manchester Centre for Genomic Medicine (MCGM) for a range of rare diseases including cancers, developmental disorders and disabilities including hearing and vision loss - diagnosis can be time-consuming and invasive. [More]
Early intervention helps improve intellectual ability, reduces autism symptoms in children

Early intervention helps improve intellectual ability, reduces autism symptoms in children

Early intervention for toddlers with autism spectrum disorder helps improve their intellectual ability and reduces autism symptoms years after originally getting treatment, a new study shows. [More]
New UF study shows that multi-tasking may improve cognitive performance

New UF study shows that multi-tasking may improve cognitive performance

A new University of Florida study challenges the notion that multi-tasking causes one or both activities to suffer. In a study of older adults who completed cognitive tasks while cycling on a stationary bike, UF researchers found that participants' cycling speed improved while multi-tasking with no cost to their cognitive performance. [More]
Fennec presents positive interim results from phase III trial of sodium thiosulphate at ASCO 2015

Fennec presents positive interim results from phase III trial of sodium thiosulphate at ASCO 2015

Fennec Pharmaceuticals, Inc., announced the presentation of positive interim results from a poster presented today entitled, "Anti-tumor efficacy in SIOPEL6: A multi-centre open label randomised phase III trial of the efficacy of sodium thiosulphate (STS) in reducing ototoxicity in patients receiving cisplatin (Cis) monotherapy for standard risk hepatoblastoma (SR-HB)." [More]
Genesis Rehab Services forms groundbreaking partnership with Zhejiang Bang-Er Medical Group

Genesis Rehab Services forms groundbreaking partnership with Zhejiang Bang-Er Medical Group

Genesis Rehab Services, a division of Genesis HealthCare, one of the nation's largest providers of post-acute care, today announced a groundbreaking partnership with Zhejiang Bang-Er Medical Group, an orthopedic hospital system in China. [More]
Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures. [More]
Modified poliovirus therapy for glioblastoma works best at a low dosage

Modified poliovirus therapy for glioblastoma works best at a low dosage

A modified poliovirus therapy that is showing promising results for patients with glioblastoma brain tumors works best at a low dosage, according to the research team at Duke's Preston Robert Tisch Brain Tumor Center where the investigational therapy is being pioneered. [More]
CHOP Global Health Center performs first rigorous study of CP outcomes in Africa

CHOP Global Health Center performs first rigorous study of CP outcomes in Africa

Cerebral palsy (CP) is the most common cause of childhood disability in the world, affecting between 1 and 2 infants per thousand. But the neurological condition tends to be understudied, especially in developing countries. [More]
Autism and apraxia often go hand-in-hand

Autism and apraxia often go hand-in-hand

Some children with autism should undergo ongoing screenings for apraxia, a rare neurological speech disorder, because the two conditions often go hand-in-hand, according to Penn State College of Medicine researchers. [More]
Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

Amgen today announced that it will present data from multiple Kyprolis (carfilzomib) for Injection, BLINCYTO (blinatumomab), oprozomib and Nplate (romiplostim)‎ studies at the 20th Congress of the European Hematology Association taking place in Vienna, June 11 - 14, 2015. [More]
UC San Diego Health System designated as Center of Excellence for Huntington's disease

UC San Diego Health System designated as Center of Excellence for Huntington's disease

The Huntington's Disease Clinical Research Center at UC San Diego Health System has been designated a Center of Excellence by the Huntington's Disease Society of America. UC San Diego was one of only 29 centers nationwide to receive this prestigious designation, which recognizes centers for their elite multidisciplinary approach to Huntington's disease care and research. [More]

Racial stereotypes can impact the way we communicate, understand others

Racial stereotypes and expectations can impact the way we communicate and understand others, according to UBC research. The new study, published in the Journal of the Acoustical Society of America, highlights how non-verbal "social cues" - such as photographs of Chinese Canadians - can affect how we comprehend speech. [More]
Advertisement
Advertisement